DJIA 16,452.78 -110.52 -0.67%
NASDAQ 4,330.57 -39.20 -0.90%
S&P 500 1,918.16 -12.51 -0.65%
market minute promo


9.40 0.02 (0.21%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

PDLI $9.40 0.21%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $9.37
Previous Close $9.38
Daily Range $9.31 - $9.50
52-Week Range $7.38 - $10.21
Market Cap $1.5B
P/E Ratio 5.39
Dividend (Yield) $0.60 (6.4%)
Ex-Dividend Date
Dividend Pay Date
Volume 640,603
Average Daily Volume 2,116,176
Current FY EPS $2.22





PDL BioPharma (PDLI) Description

A biopharmaceutical company focused on discovering, developing and commercializing innovative therapies for severe or life-threatening illnesses. Website:

News & Commentary

2 Health Care Partnerships Go Head-To-Head

While the partnership between GlaxoSmithKline (NYSE: GSK) and Ligand (NASDAQ: LGND) seems to be moving forward, the partnership between Roche (OTCMKTS: RHHBY) and PDL (NASDAQ: PDLI) has seemingly reached its end

What To Buy: Top 3 Buy-Rated Dividend Stocks: HCN, PDLI, EEP

Best High-Yielding Stocks According To Greenblatt Principles: PDL BioPharma

Top 4 NASDAQ Stocks In The Biotechnology Industry With The Lowest PEG Ratio

Buy-Rated Dividend Stocks: Top 3 Companies: ETR, PDLI, T

PDL BioPharma: Panning For Dividend Gold

PDL BioPharma Views Lower Q2 Revenues - Analyst Blog

Top 3 Yielding Buy-Rated Stocks: LHO, MPW, PDLI

Ex-Dividends For June 3, 2014

Dividend Watch: 3 Stocks Going Ex-Dividend Tomorrow: ERF, ARP, PDLI

PDL BioPharma, Inc. (PDLI) Ex-Dividend Date Scheduled for June 03, 2014

See More PDLI News...

PDLI's Top Competitors

PDLI $9.40 (0.21%)
Current stock: PDLI
AMGN $125.10 (-1.80%)
Current stock: AMGN
GILD $91.07 (-0.52%)
Current stock: GILD
BIIB $327.84 (-1.96%)
Current stock: BIIB